We investigated recurrent stroke volume with nonvalvular atrial fibrillation (NVAF) patients treated with non–vitamin K antagonist oral anticoagulants (NOACs) about clinical backgrounds and number of recurrent stroke.

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...